As of 4:00pm ET
| -0.11 / -4.53%|
The 5 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +50.86% increase from the last price of 2.32.
The current consensus among 5 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.